Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Fresh Tracks Therapeutics Inc
FRTX
Healthcare
Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:FRTX)
New Post
View:
Posts & Comments
Threaded Posts
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 12:57pm
Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX): Navigating th
https://beyondspx.com/2024/08/03/fresh-tracks-therapeutics-inc-nasdaqfrtx-navigating-the-dissolution-and-maximizing-shareholder-value/
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 20, 2022 9:50am
BBI .... You've all been had by Mr. Maggot
sub 28 and it's all over but the cryin ! Cheers !
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 19, 2022 11:36am
BBI ..... Well here is when it gets real ugly!
Currently trading at $0.2940 ....has to hold $0.2892.....because the next support is at $0.2648....then back to 0.00
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 19, 2022 11:08am
BBI .....read my last post
sometimes it takes awhile Cheers !
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 18, 2022 1:27pm
BBI ....start the f'ing drumroll
Sub 34 .....28 ...here we come.....LoL
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 18, 2022 12:22pm
BBI.....I've scalped thi 2 x's this a.m ; )
Volume & Price action is sweet Now in PB mode and has a Strike 2 warning..... my handicapping system ; ) Has to hold $0.34 or it's fast drop to $0.29 Currently trading at $0.3492
...more
(2)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Mar 18, 2021 9:33am
Good action today
Added more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Feb 11, 2021 4:46am
COVID-19 Vaccine Opportunity
Summary Brickell has rights to commercialize Japanse partner's AnGes proprietary COVID-19 plasmid DNA vaccine in the U.S., South America and certain emerging markets per a September 2020
...more
(2)
•••
Dxm476
X
View Profile
View Bullboard History
Post by
Dxm476
on Feb 10, 2021 9:22am
Easier on the eyes.
Currently trading at $1.25 as of February 5th, Brickell Biotech’s stock has potential to hit $5+ by late-March and $30+ by EOY. Let’s dive into why: BBI has been quite dormant due to lack of PR &
...more
(2)
•••
Dxm476
X
View Profile
View Bullboard History
Comment by
Dxm476
on Feb 10, 2021 9:19am
RE:5-6 dollars plus in 2021.
Sorry about the bad background there. When I copied it it took the black with it...
(2)
•••
Dxm476
X
View Profile
View Bullboard History
Post by
Dxm476
on Feb 10, 2021 9:18am
5-6 dollars plus in 2021.
Currently trading at $1.25 as of February 5th, Brickell Biotech’s stock has potential to hit $5+ by late-March and $30+ by EOY. Let’s dive into why: BBI has been quite dormant due to lack of PR &
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Meet the Top 5 Best Online Brokerages in Canada
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Star Diamond Corporation Announces Third Quarter 2024 Results